Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

High-Dose Melphalan-Based Sequential Conditioning Chemotherapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Christoph Groth, MD, Nina Kristin Steckel, MD, Jan-Henrik Mikesch, Rudolf Trenschel, MD, Hellmut Dietmar Ottinger, MD PhD, Carsten Müller-Tidow, Christoph Schliemann, Christian Reicherts, Eva Schmidt, Wolfgang E. Berdel, Georg Lenz, Markus Ditschkowski, Dietrich W Beelen, MD PhD, Matthias Stelljes, MD

Blood (2017) 130 (Supplement 1): 3205.

https://doi.org/10.1182/blood.V130.Suppl_1.3205.3205

Published: 2017

Journal Articles

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Blood (2017) 130 (Supplement 1): 4586.

https://doi.org/10.1182/blood.V130.Suppl_1.4586.4586

Published: 2017

Journal Articles

Final Results of a Prospective Randomized Multicenter Phase III Trial Comparing Treosulfan/Fludarabine to Reduced Intensity Conditioning with Busulfan/Fludarabine Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Elderly or Comorbid Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Dietrich W Beelen, MD PhD, Rudolf Trenschel, MD, Matthias Stelljes, MD, Tamás Masszi, MD Prof., Péter Reményi, Eva-Maria Maria Wagner-Drouet, MD, Peter Dreger, MD Prof., Wolfgang Bethge, MD Prof., Fabio Ciceri, MD, Friedrich Stoelzel, MD, Christian Junghanss, MD, Mauricette Michallet, MD Prof., Miroslaw Markiewicz, MD Prof.

Blood (2017) 130 (Supplement 1): 521.

https://doi.org/10.1182/blood.V130.Suppl_1.521.521

Published: 2017

Journal Articles

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Nina Kristin Steckel, M.D., Markus Ditschkowski, MD, Christoph Groth, M.D., Gerda Silling, MD, U. Krug, MD, Rudolf Trenschel, MD, Hellmut Ottinger, MD, Wolfgang E Berdel, MD, Michael Koldehoff, MD, Ahmet H. Elmaagacli, Dietrich Beelen, MD, Matthias Stelljes, MD

Blood (2013) 122 (21): 4525.

https://doi.org/10.1182/blood.V122.21.4525.4525

Published: 2013

Journal Articles

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina Kristin Steckel, Markus Ditschkowski, Rudolf Trenschel, MD, Hellmut Ottinger, Dietrich W. Beelen, MD

Blood (2012) 120 (21): 4182.

https://doi.org/10.1182/blood.V120.21.4182.4182

Published: 2012

Journal Articles

Conditioning with Treosulfan and Fludarabine for Patients with Refractory or Relapsed Non-Hodgkin Lymphoma (NHL),

Michael Schmitt, Rudolf Trenschel, MD, Herbert G. Sayer, MD, PhD, Catarina Schneider, Aenne Glass, Inken Hilgendorf, Anne Treschl, MD, Christian Junghanss, MD, Kersten Borchert, Michael Koenigsmann, Jochen Casper, MD, Dietrich Beelen, Mathias Freund, Christoph Kahl

Blood (2011) 118 (21): 4106.

https://doi.org/10.1182/blood.V118.21.4106.4106

Published: 2011

Journal Articles

Early Lenalidomide Maintenance to Prevent Relapse of High-Risk MDS and AML Patients with Del(5q) Following Allogeneic HCT - Results of the “LENAMAINT” Trial

Katja Sockel, MD, Jochen Greiner, MD, Rudolf Trenschel, MD, Christian Unzicker, MD, Guido Kobbe, MD, Jürgen Finke, MD, Ulrich Germing, MD, Brigitte Mohr, Dietrich Beelen, Gerhard Ehninger, MD, Martin Bornhaeuser, Uwe Platzbecker, MD

Blood (2011) 118 (21): 3060.

https://doi.org/10.1182/blood.V118.21.3060.3060

Published: 2011

Journal Articles

Treosulfan Compared to Total Body Irradiation-Based Preparative Regimens Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia : A Retrospective Long-Term Study.

Dietrich Wilhelm Beelen, MD, Tanja Gromke, MD, Rudolf Trenschel, MD, Inken Hilgendorf, MD, Daniel Wolff, MD, Ahmet Elmaagacli, MD, Mathias Freund, MD, Jochen Casper, MD

Blood (2008) 112 (11): 2149.

https://doi.org/10.1182/blood.V112.11.2149.2149

Published: 2008

Journal Articles

Genetic Polymorphisms in Chemokine Receptor 5 , Interleukin 10 and Monocyte Chemoattractant Protein 1 Contribute to Cytomegalovirus Reactivation and Disease after Allogeneic Stem Cell Transplantation.

Juergen Loeffler, PhD, Michael Steffens, MD, Eva-Maria Arlt, Mohammad-Reza Toliat, Thomas Wienker, MD, Holger Hebart, MD, Michael Boeckh, MD, Per Ljungman, MD, Rudolf Trenschel, MD, Hermann Einsele, MD

Blood (2005) 106 (11): 3248.

https://doi.org/10.1182/blood.V106.11.3248.3248

Published: 2005

Journal Articles

Improved Outcome of Patients with Invasive Pulmonary Fungal Infection Complicated by Respiratory Failure Due to the Use of New Antimycotis Agens and Early Tracheostomy after Allogeneic Transplantation.

Michael Koldehoff, MD, Ahmet H. Elmaagacli, MD, PH, Nina K. Steckel, MD, Rudolf Trenschel, MD, Michal Hlinka, Markus Ditschkowski, MD, Harald Biersack, MD, Dietrich W. Beelen, MD, PH

Blood (2005) 106 (11): 5355.

https://doi.org/10.1182/blood.V106.11.5355.5355

Published: 2005

Journal Articles

Detection of the Acquired Tyrosine Kinase JAK2 Gene Mutation by Real Time PCR as Minimal Residual Disease Marker for Patients after Allogeneic Hematopoetic Stem Cell Transplantation.

Ahmet H. Elmaagacli, MD, Nina K. Steckel, MD, Michael Koldehoff, MD, Markus Ditschkowski, MD, Rudolf Trenschel, MD, Dietrich W. Beelen, MD

Blood (2005) 106 (11): 1212.

https://doi.org/10.1182/blood.V106.11.1212.1212

Published: 2005

Journal Articles

VEGF Specific siRNAs Act Synergistically with Bortezomib and Steroids in Inhibiting VEGF Gene Expression, Proliferation and Induction of Apoptosis in Multiple Myeloma Cells.

Michael Koldehoff, MD, Nina K. Steckel, Rudolf Trenschel, MD, Dietrich W. Beelen, MD, PH, Ahmet H. Elmaagacli, MD, PH

Blood (2004) 104 (11): 5266.

https://doi.org/10.1182/blood.V104.11.5266.5266

Published: 2004

Journal Articles

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Ahmet Elmaagacli, MD, Helmut Ottinger, MD, Micheal Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 5049.

https://doi.org/10.1182/blood.V104.11.5049.5049

Published: 2004

Journal Articles

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

Ahmet H. Elmaagacli, MD, Hellmut Ottinger, MD, Koldehoff Michael, MD, Peceny Rudolf, MD, Nina K. Steckel, MD, Rudolf Trenschel, MD, Harald Biersack, MD, Hans Grosse-Wilde, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 974.

https://doi.org/10.1182/blood.V104.11.974.974

Published: 2004

Journal Articles

Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Ahmet Elmaagacli, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Rudolf Peceny, MD, Helmut Ottinger, MD, Michael Koldehoff, MD, Harry Biersack, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 3343.

https://doi.org/10.1182/blood.V104.11.3343.3343

Published: 2004

NARROW

High-Dose Melphalan-Based Sequential Conditioning Chemotherapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Conditioning with Treosulfan and Fludarabine for Patients with Refractory or Relapsed Non-Hodgkin Lymphoma (NHL),

Early Lenalidomide Maintenance to Prevent Relapse of High-Risk MDS and AML Patients with Del(5q) Following Allogeneic HCT - Results of the “LENAMAINT” Trial

Treosulfan Compared to Total Body Irradiation-Based Preparative Regimens Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia : A Retrospective Long-Term Study.

Genetic Polymorphisms in Chemokine Receptor 5 , Interleukin 10 and Monocyte Chemoattractant Protein 1 Contribute to Cytomegalovirus Reactivation and Disease after Allogeneic Stem Cell Transplantation.

Improved Outcome of Patients with Invasive Pulmonary Fungal Infection Complicated by Respiratory Failure Due to the Use of New Antimycotis Agens and Early Tracheostomy after Allogeneic Transplantation.

Detection of the Acquired Tyrosine Kinase JAK2 Gene Mutation by Real Time PCR as Minimal Residual Disease Marker for Patients after Allogeneic Hematopoetic Stem Cell Transplantation.

VEGF Specific siRNAs Act Synergistically with Bortezomib and Steroids in Inhibiting VEGF Gene Expression, Proliferation and Induction of Apoptosis in Multiple Myeloma Cells.

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only